Summary. Disorders of executive functioning have recently been reported in patients with juvenile myoclonic epilepsy (JME);
Introduction
Idiopathic generalized epilepsies (IGEs) of adolescence comprise a group of age-related epilepsy syndromes characterized by generalized seizures that have a genetic origin and no detectable brain lesion (1, 2) . IGE is considered a benign condition; patients usually have normal intellectual abilities, and their seizures are well controlled with antiepileptic drugs. Yet, the studies that evaluated intellectual abilities of patients with IGE have shown a tendency to lower IQ than in general population (3) (4) (5) . The impairment of various cognitive functions such as attention, memory, and executive functions in patients with IGE has been reported (4, (6) (7) (8) . The impairment of certain cognitive functions is very important in school-aged patients since it may infl uence their learning process and lead to psychosocial and professional impact even for children with normal intelligence and well-controlled seizures (4, 9) . Idiopathic epilepsies without structural brain changes constitute a better model for evaluating the impact of disease-related characteristics and paroxysmal epileptic activity on cognitive functions than symptomatic epilepsies (10) , and therefore investigations of various aspects of cognition in idiopathic epilepsies are in process. Recently, executive functions, mainly associated with the function of the frontal cortex, have gained much attention and have been studied in patients with epilepsy, particularly in case of juvenile myoclonic epilepsy (JME) (11) (12) (13) (14) . Executive functions are a complex set of processes, thought to be responsible for the ability to plan and form abstract concepts and goals, adjust to changing demands and new instructions, control attention, impulsivity, and emotions (15, 16) , and thus are very important in everyday life and learning process. Data from studies involving patients with JME show a range of defi cits in various executive functions (6, (11) (12) (13) suggesting the impairment of frontal and prefrontal regions. Neuroimaging studies revealing subtle structural abnormalities in the prefrontal region (17) (18) (19) (20) suggest a frontal lobe dysfunction in JME and even raise a question if JME is a truly generalized epilepsy syndrome. However, results of the studies are inconsistent, and there is some evidence that slight abnormalities of frontal lobes in JME should be taken with care of overinterpretation (14, 21) . It remains unclear if impaired executive functions are common features of IGE, with very few studies addressing this issue and the results being not uniform (7, 9, 22) . Another question is if these impairments are constant or dependent on a reversible transient impact of seizures or interictal discharges (10) . In general, there is a lack of studies addressing cognitive domains of adolescent patients with IGE and its syndromes, since some of the studies related to this age group analyzed both partial and generalized idiopathic epilepsies together (8, (22) (23) (24) .
The aim of this cross-sectional study was to analyze the specifi c executive functions in a group of adolescents with IGE of short duration and to evaluate the possible seizure-related factors that may infl uence these functions.
Material and Methods
Subjects. The study group comprised the patients with idiopathic generalized epilepsy aged 14-17 years who were followed up at the tertiary center (Department of Neurology, Hospital of Lithuanian University of Health Sciences Kaunas Klinikos) during 2009-2010. The study was approved by the Regional Bioethics Committee and the State Data Protection Inspectorate, and all the patients and their parents signed their informed consent. Inclusion criteria were as follows: age of 14-17 years; mainstream education and IQ>70 (WISC III, Lithuanian version, neuropsychological evaluation was performed by a licensed clinical psychologist); IGE diagnosis based on clinical and electroencephalography (EEG) criteria (1, 2) (the specifi c EEG characteristics being present either during the study period or any time before) and no clinical or structural brain imaging evidence of organic brain damage; no history of brain trauma with loss of consciousness; no diagnosis of any neurological, psychiatric, or chronic somatic disorders; and no generalized tonic clonic seizures (GTCSs) within the last 24 hours. Patients with absences as the only seizure type were excluded. According to these criteria, 59 adolescents were enrolled. Duration of epilepsy was set as the period from the fi rst unprovoked seizure until the date of the study.
According to the treatment and time of diagnosis, IGE patients were divided into the newly diagnosed and previously untreated IGE group ("newonset") and the group of patients with previously established IGE and treated with antiepileptic drugs ("established"). All patients in the established IGE group were treated properly with suffi cient doses of medications.
Because of the diffi culties in evaluating seizure frequency in the new-onset epilepsy cases and comparing it to the seizure frequency of patients with established epilepsy, not the seizure frequency but rather the presence of seizure activity within the past 3 months before the study was assessed.
Since myoclonic jerks are considered to be obligatory for the diagnosis of JME (2), the patients were divided into two groups according to the presence (M+) or absence (M-) of myoclonic jerks: those with myoclonic jerks were defi ned as having JME, and patients without myoclonias and with GTCSs as the only seizure type (or in combination with infrequent absences) were defi ned as having IGE with "GTCSs only." Myoclonias were considered as "active" if patients had myoclonic jerks within the past 3 months occurring at least 3 days per week.
The control group consisted of 59 adolescents matched by age and meeting all the inclusion criteria except of epilepsy at any time of their lives.
Methods. All subjects both of the study and the control group were exposed to four batteries for the evaluation of executive functions: the Verbal Fluency Test, the Five-Point Test, the Trail-Making Test (TMT), and the Stroop Test.
Verbal Fluency. The Verbal Fluency Test evaluates the spontaneous production of words under restricted search conditions. Generation of words that begin with a certain letter (phonemic fl uency) or belonging to a certain category by their meaning (semantic fl uency) within a limited time is used to assess verbal association fl uency and mental retrieval from long-term memory (16) . For the analysis of phonemic fl uency, the sum of all admissible words for three letters (F, A, and S) was used, and for the semantic fl uency analysis, the sum of correct words representing given categories ("Food" and "Animals") was used.
Five-Point Test. This test has been developed as a nonverbal analog to word fl uency tasks to measure the production of novel designs under time constraints (16) . Patients were asked to produce as many different fi gures as possible by connecting the dots within presented matrix in 3 minutes. For the analysis, the total number of unique designs and the percentage of repeated designs (perseverations) were used.
Trail-Making Test. The TMT is a measure of speed of attention, sequencing, mental fl exibility, visual search, motor function, and working memory (16) . The subjects had to connect 25 numbered circles scattered randomly in an ascending order (Part A) and 25 circles with numbers and letters both in an ascending order and in an alternating way (Part B). The time in seconds required for the performance of Part A and Part B was used for the analysis.
Stroop Test. The test is aimed at the evaluation of the ease with which a person can maintain a goal in mind and suppress a habitual response in favor of a less familiar one. It also assesses selective attention, susceptibility to interference, and cognitive fl exibility. The Victoria version of this test was used (16) . For the analysis, the difference between the execution time of the third ("words") and the fi rst ("colors") tasks in seconds and the number of errors/autocorrections during the third task were evaluated.
The results of the tests were initially compared between the IGE group and the control group. Later, comparisons of the control group and the subgroups of IGE according to the duration of epilepsy (new-onset and established IGE) and to epilepsy syndrome (JME and IGE with GTCSs only) were performed, followed by the comparisons of the test results according to the demographic and clinical characteristics within the IGE group.
Statistical Analysis. Data were statistically analyzed by using the SPSS 15.0 for Windows statistical software (SPSS Inc., Chicago, IL, USA). Parameters were evaluated using the Kolmogorov-Smirnov test for the normality of distribution and the Levene test for homogeneity. Parametric and nonparametric statistics were applied where appropriate. Group comparisons were made based on the independent samples t test, Mann-Whitney U test, one-way ANOVA and Kruskal-Wallis ANOVA tests. If significant differences were found, post hoc comparisons were performed using the least signifi cant difference (LSD) procedure or Mann-Whitney test (with Bonferroni adjustment). To investigate the relationship between variables, the Spearman correlation was used. The differences were considered statistically signifi cant when P values were less than 0.05. . The mean age at the onset of epilepsy in the IGE groups was 13.6 (SD, 2.6) years. The mean duration of active epilepsy was 14.1 months (median, 7 months; interquartile range, 22.5) . Clinical data of the IGE group are presented in Table 1 .
Results

Demographic and Clinical
Within the past 3 months, 41 patients (69.5%) had at least one GTCS; the median frequency of GTCS during that period was 1.0 (min, 0; max, 9). There was no difference between the new-onset and the established IGE groups with regard to gender and schooling years, although patients with newonset IGE were younger than their counterparts in the established IGE group: 15.2 years (SD, 1.2) and 15.8 years (SD, 1.1) respectively (P=0.032). In the established IGE group, the majority of subjects received monotherapy: 20 (74.1%) were treated with valproic acid, 4 (14.8%) with lamotrigine, and 3 patients (11.1%) were administered both drugs.
Generalized paroxysmal discharges on background EEG were recorded in a larger proportion of patients in the new-onset IGE group compared with the established epilepsy group: 15 of the 30 patients (46.9%) and 5 of the 29 patients (18.5%), respectively (P=0.029). However, the presence of discharges on sleep EEG did not differ between these groups.
There were more newly diagnosed patients in the M (-) group than in the M (+) group (21 of 
019).
The M (-) and the M (+) groups did not differ according to other demographic characteristics (age, sex) and clinical variables (remission for at least three months, the occurrence and the number of GTCSs over the past three months, time-span since the last GTCS, age at the onset of epilepsy, presence of paroxysmal discharges on EEG).
Evaluation of Executive Functions. The results of all the tests of executive functions obtained in the IGE group, with its further subdivision into the new-onset IGE and the established IGE subgroups and also into the M (-) IGE and the M (+) IGE subgroups, and the control group are summarized Table 2 .
The total IGE group scored worse than the control group in all the tests for executive functions although not all the differences were signifi cant. The IGE group subjects generated fewer items in phonemic task (P=0.008), semantic task (P=0.001), and they compounded fewer fi gures during the Five-Point Test (P=0.008) as compared to controls. The percentage of fi gure repetition did not differ between the groups. The performance time for the TMT Part A and Part B was longer in the IGE group (P=0.001 and P=0.018, respectively). The time difference score of the Stroop Test was higher in the IGE group but did not reach statistical signifi cance (P=0.053), and the number of errors/autocorrections during the third task did not differ between the IGE and control groups.
None of the test scores differed between the No difference in the results of any of the tests was found between the M (+) group and the M (-) group, and the group effects accounted only for the control group when M (-) IGE, M (+) IGE, and the control groups were compared. The scores in phonemic fl uency of the M (-) group (P=0.016), and semantic fl uency of both the M (-) and the M (+) groups (P=0.001 and P=0.023 respectively) were worse than those of the control group. The Five-Point Test score of the M (-) group was lower as compared with the control group (P=0.008). TMT Part A time scores in the M (-) group and Part B time scores in the M (+) group were higher as compared with the control group (P=0.001 and P=0.002, respectively). The Stroop Test score and the number of errors did not differ among the M (+), the M (-), and the control groups. In the M (+) group, the scores did not differ in cases with active and inactive myoclonic jerks.
In the IGE group, the age at epilepsy onset and the Five-Point Test score (the number of fi gures produced) showed a positive correlation (r=0.38, P=0.003), while the scores of other executive function tests showed no correlation with this variable.
Correlation was identifi ed between the number of GTCSs within 3 months and the number of errors in the third task of the Stroop Test (r=0.47, P=0.001); in addition, a negative correlation was identifi ed between the latter score and the time since the occurrence of the last GTCS (r=-0.3, P=0.027). The scores of other tests showed no correlation with either the number of GTCSs during the past 3 months or with the period after the last GTCS. Executive functions did not differ between the IGE patients in remission during the past 3 months and the ones without it, except for the error number in the Stroop Test, which was lower in the IGE group in remission (1.3 [SD, 1.2] and 0.3 [SD, 0.4], respectively; P=0.024). No correlation of executive functioning with the duration of active epilepsy was identifi ed, also between the IGE groups with paroxysmal discharges on the background or sleep EEG and without them. There was no correlation between the age at the time of the study and the executive function test scores in both the IGE and control groups, and also any difference with regard to gender of the participants.
Discussion
The patients in the IGE group of adolescents with normal IQ (>70) and epilepsy of relatively short duration scored worse than the controls in most of the executive function tests used in this study: phonemic and semantic word fl uency, fi gural fl uency, visuomotor functioning and sequencing, except for the scores of the Stroop Test that measures the functions of selective attention and cognitive fl exibility.
These results are consistent with previous studies that have reported impaired frontal functioning in patients with IGE (6, 7, 11, 12, 25, 26) , although the range of impaired functions reported has not been uniform, e.g., some studies showed the disturbance only in the tasks for verbal fl uency and no difference from the control group in other tests (14, 21) . These differences in results may have several explanations, one of them being the complexity of executive functioning and the possibility that not all the domains should be necessarily impaired. In addition, the performance of individual IGE patients may be not uniform, with some of them showing little or no defi cit of the tested executive functions (6), the explanation under consideration being the genotypic and phenotypic heterogenicity of patients with IGE (27) . Since most of the studies evaluating executive functions have included patients with JME (6, 11-14, 21, 25, 26) and only few have investigated patients with other IGE syndromes (7, 22, 23, (28) (29) (30) (some of them having included patients with both partial and generalized idiopathic epilepsies), more data about the executive functions in IGE syndromes other than JME are necessary. Executive functions in the subgroups of IGE patients with GTCS only and those diagnosed with JME have been analyzed, and no difference between these two groups in any of the tests for executive functions used in this study has been found.
Analysis of the results within the IGE group with GTCS only revealed that these patients performed worse than controls in various domains of executive functioning: the phonemic and semantic verbal fl uency, fi gural fl uency, and TMT Part A test. Publications concerning the evaluation of the executive function in patients with IGE with GTCS only are scarce and results are variable. Henkin et al. did not fi nd impaired word fl uency in patients with GTCS compared to controls (7), while some other studies that included patients with GTCS found affected executive functions with no difference according to epilepsy syndrome (30) or seizure type (28) . There are published data about the impairment of executive functioning in patients with absence epilepsy (7, 29) . These fi ndings imply that the impairment of executive functions may be present in other IGE syndromes.
Patients with JME performed worse just in two tests when compared with the control group: the tests of semantic word fl uency and TMT Part B, the tasks that require organized thinking, attention, and cognitive fl exibility. These fi ndings contribute to the data of other studies, claiming that executive functions may be affected in patients with JME. However, our data show fewer impaired domains of executive functioning in the JME group as compared with some other studies (6, 11, 12) , although there are other reports about the lack of extensive defi cit of executive function in patients with JME (14, 21) . Taken these results together, we suggest that in some patients with JME of short duration, executive functioning may be only mildly affected, and subtle differences should be taken with caution in order to avoid overinterpretation.
According to the recognized diagnostic criteria, brain structural abnormalities in IGE should not be expected. However, the recent fi ndings about the disorders of executive functions in JME have stimulated more sophisticated investigations on brain structure and functioning. Hutchinson et al. confi rmed microstructural abnormalities in the white and gray matter of the frontal, parietal, temporal, occipital lobes and posterior corpus callosum in children with idiopathic new-onset epilepsy, although the study group included both generalized and partial epilepsy (31) . Brain tissue abnormalities in the thalamic and frontal regions have been detected in children with recent IGE (32) and adults with JME (33); patients with GTCS only had a reduced gray matter fraction in multiple regions of the cortex including the frontal zone (34) . Some other investigators, however, have not confi rmed these fi ndings in the thalamic (35) or frontal regions (14) . Moeller et al. in their study of 6 children with IGE (only one of them being a JME case) by combined EEG-fMRI investigation have reported that a generalized epileptic discharge on EEG was preceded by a sequence of neuronal events in the thalamo-cortical (frontoparietal)-striatal network (36) , thus supplementing the data on localization-related structural characteristic features of the brain in IGE. The results of our study support the fi ndings of previous reports on neuropsychology and neuroimaging that the disorders of executive function are characteristic of IGE. Our data have added some evidence that IGE presenting with myoclonias may not demonstrate any closer relationship to the disturbance of executive functions as compared with syndromes of adolescent IGE without myoclonias. As most of the studies have investigated JME, which is the bestdelineated IGE syndrome, further explorations of the brain functioning in other IGE syndromes may be relevant in the future.
The question under discussion is when the impairment of executive functioning and volumetric brain changes in patients with IGE take place. Is this related to the duration of epilepsy, seizure frequency, or treatment? The impairment of cognition including executive functions in patients with recent idiopathic epilepsy has been detected (23, 30) . Pulsipher et al. have also found executive dysfunction and volumetric changes in adolescents with recent epilepsy, although all their patients received antiepileptic treatment (25) . In our series with relatively recent epilepsy, the results of executive functioning did not differ between the newly diagnosed untreated and established IGE patients receiving AED, and both the groups scored worse than the controls in a range of tests evaluating executive functions. The analysis of the possible correlation of executive functioning with seizure frequency, the number of recent GTCSs, or the time interval from the last GCTS showed that only the number of errors in the Stroop Test was related to the abovementioned factors. It might implicate that recent active seizures are associated with a higher level of distractibility, although the variability of the results in this test and the small number of patients that made errors attenuate the interpretation of this correlation. No other results showed relationships to any of the evaluated clinical characteristics, except the young age at seizure onset, which demonstrated a single positive correlation with the scores for fi gural fl uency. We refrain from further speculations on the latter isolated fi nding since no other signifi cant correlations of this variable were found.
The results of our study support the hypothesis that executive dysfunction (and possibly the volumetric brain changes) is more related to certain epilepsy syndromes rather than to the duration and the severity of epilepsy. These presumptions are supported by the fact that idiopathic focal epilepsy of the same duration has been related neither to the executive dysfunction nor to the structural or functional changes in the frontal regions (25, 37) . The above mentioned volumetric and structural evaluations support the hypothesis that cognitive dysfunction and associated structural and/or functional changes, especially in adolescents with recent epilepsy, possibly have a genetic predisposition (32) . The impact of seizure frequency, long-lasting epilepsy course, and medications remains unclear because of interaction of these factors.
Conclusions
Risk of the impairment of executive functioning exists in adolescents with idiopathic generalized epilepsy despite of short duration and benign course of epilepsy. Patients in our study demonstrated impaired verbal and fi gural fl uency, sequencing and visual search, while cognitive fl exibility and susceptibility to interference were comparable with age-matched controls. Executive functioning in this young patient population was not related to the duration or the activity of epilepsy, the exposure to antiepileptic drugs, or the presence or absence of myoclonias. We conclude that executive dysfunction may be present in other idiopathic generalized epilepsy syndromes of adolescence, not being the exceptional feature of juvenile myoclonic epilepsy. As the impairment of executive functions is very important in adolescents with epilepsy for its impact on the learning process, we suggest a neuropsychological evaluation in patients with idiopathic generalized epilepsy early in the course of the disease in order to provide adequate intervention when necessary.
